Redo AF Sub Study (of the Pure EP 2.0 Main Study)
Completed
- Conditions
- Atrial Fibrillation Recurrent
- Interventions
- Device: Pure-EP
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- BioSig Technologies, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04964440
- Locations
- 🇺🇸
St. David's Medical Center, Austin, Texas, United States
Novel Cardiac Signal Processing System
Completed
- Conditions
- Cardiac Arrhythmia
- Interventions
- Device: PURE EP 2
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- BioSig Technologies, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT04112433
- Locations
- 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸St. David's Medical Center, Austin, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath